Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Boire

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
The Journal of Rheumatology|September 3, 2015
Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis CohortJenny Shu, Vivian P Bykerk, Gilles Boire, et al.
The Journal of Rheumatology|August 17, 2012
The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activityVivian P Bykerk, Shahin Jamal, Gilles Boire, et al.
Arthritis Research & Therapy|May 19, 2005
Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritisGilles Boire, Pierre Cossette, Artur J de Brum-Fernandes, et al.
Health|November 3, 2015
What Do We Know about Individuals Who Are Assessed as Being at Moderate Risk for Future Fracture in Canada?Joanna E M Sale, Ravi Jain, Kosalan Akilan, et al.
The Journal of Rheumatology|August 19, 2010
Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX(®)Carly K Cheng, Heather McDonald-Blumer, Gilles Boire, et al.
The Journal of Rheumatology|November 17, 2014
Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohortGrace Yang, Vivian P Bykerk, Gilles Boire, et al.
Rheumatology International|August 31, 2013
Factors associated with time to diagnosis in early rheumatoid arthritisCheryl Barnabe, Juan Xiong, Janet E Pope, et al.
Arthritis Research & Therapy|April 23, 2014
14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damageWalter P Maksymowych, Désirée van der Heijde, Cornelia F Allaart, et al.
The Journal of Rheumatology|October 3, 2014
Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritisLillian Barra, Janet E Pope, John E Orav, et al.
Arthritis and Rheumatism|November 28, 2008
Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosisMartial Koenig, France Joyal, Marvin J Fritzler, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Rheumatology|September 3, 2015
Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis CohortJenny Shu, Vivian P Bykerk, Gilles Boire, et al.
The Journal of Rheumatology|August 17, 2012
The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activityVivian P Bykerk, Shahin Jamal, Gilles Boire, et al.
Arthritis Research & Therapy|May 19, 2005
Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritisGilles Boire, Pierre Cossette, Artur J de Brum-Fernandes, et al.
Health|November 3, 2015
What Do We Know about Individuals Who Are Assessed as Being at Moderate Risk for Future Fracture in Canada?Joanna E M Sale, Ravi Jain, Kosalan Akilan, et al.
The Journal of Rheumatology|August 19, 2010
Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX(®)Carly K Cheng, Heather McDonald-Blumer, Gilles Boire, et al.
The Journal of Rheumatology|November 17, 2014
Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohortGrace Yang, Vivian P Bykerk, Gilles Boire, et al.
Rheumatology International|August 31, 2013
Factors associated with time to diagnosis in early rheumatoid arthritisCheryl Barnabe, Juan Xiong, Janet E Pope, et al.
Arthritis Research & Therapy|April 23, 2014
14-3-3η is a novel mediator associated with the pathogenesis of rheumatoid arthritis and joint damageWalter P Maksymowych, Désirée van der Heijde, Cornelia F Allaart, et al.
The Journal of Rheumatology|October 3, 2014
Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritisLillian Barra, Janet E Pope, John E Orav, et al.
Arthritis and Rheumatism|November 28, 2008
Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosisMartial Koenig, France Joyal, Marvin J Fritzler, et al.
Pageof 13